Latest filing published 26 Oct 2026 for EXOZYMES INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Damien Alan Perriman: trading record in brief
All filings by Damien Alan Perriman on record concern Exozymes Inc. We count 5 filings; the first trade dates from 1 April 2026 and the latest from 12 October 2026.
The open-market record consists of 1 sale worth €17k, with no purchase. The rest of the record consists of 2 share grants and 2 option exercises.
The latest filing, published on 26 October 2026, reports an option exercise in Exozymes Inc. The median gap between a trade and its publication by SEC (Form 4) is 7 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Damien Alan Perriman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,922 sharesCommon StockSEC:0001493152-26-048493:0
- 3,729 shares@ US$5.2096Common StockSEC:0001493152-26-048493:1
- 19,612 sharesCommon StockSEC:0001493152-26-040129:0
- 62,759 shares0Restricted Stock Grant for Common StockSEC:0001493152-26-015761:0
- 8,887 shares@ US$8.44100.0% of flowCOMMON STOCKSEC:0001493152-26-015630:0
5 of 5 declarations